Coherus BioSciences Inc (CHRS)
0.67
-0.05
(-7.33%)
USD |
NASDAQ |
Nov 04, 16:00
0.6701
0.00 (0.00%)
Pre-Market: 08:50
Coherus BioSciences Debt to Equity Ratio: -3.14 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2024 | -3.14 |
March 31, 2024 | -5.800 |
December 31, 2023 | -2.447 |
September 30, 2023 | -3.539 |
June 30, 2023 | -2.702 |
March 31, 2023 | -2.40 |
December 31, 2022 | -3.428 |
September 30, 2022 | -4.844 |
June 30, 2022 | -18.60 |
March 31, 2022 | 33.47 |
December 31, 2021 | 4.178 |
September 30, 2021 | 3.114 |
June 30, 2021 | 2.599 |
March 31, 2021 | 3.172 |
December 31, 2020 | 1.438 |
September 30, 2020 | 1.576 |
June 30, 2020 | 1.884 |
March 31, 2020 | 1.138 |
December 31, 2019 | 1.696 |
September 30, 2019 | 3.173 |
June 30, 2019 | -44.46 |
March 31, 2019 | -4.586 |
Date | Value |
---|---|
December 31, 2018 | -2.671 |
September 30, 2018 | 8.287 |
June 30, 2018 | 1.620 |
March 31, 2018 | -56.84 |
December 31, 2017 | 3.193 |
September 30, 2017 | 1.802 |
June 30, 2017 | 3.140 |
March 31, 2017 | 1.287 |
December 31, 2016 | 4.884 |
September 30, 2016 | 3.040 |
June 30, 2016 | -1.636 |
March 31, 2016 | -1.505 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | |
December 31, 2013 | -0.0992 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-18.60
Minimum
Jun 2022
33.47
Maximum
Mar 2022
0.3874
Average
1.138
Median
Mar 2020
Debt to Equity Ratio Benchmarks
Repligen Corp | 0.2956 |
Evoke Pharma Inc | 1.876 |
Personalis Inc | 0.0203 |
Maravai LifeSciences Holdings Inc | 1.196 |
Tempus AI Inc | 4.504 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 674.86M |
Total Liabilities (Quarterly) | 758.96M |
Shareholders Equity (Quarterly) | -84.11M |
Current Ratio | 1.205 |
Net Debt Paydown Yield | 20.83% |